373 related articles for article (PubMed ID: 34713231)
1. CRISPR-Based Genetic Manipulation of
Uthayakumar D; Sharma J; Wensing L; Shapiro RS
Front Genome Ed; 2020; 2():606281. PubMed ID: 34713231
[TBL] [Abstract][Full Text] [Related]
2. The CRISPR toolbox in medical mycology: State of the art and perspectives.
Morio F; Lombardi L; Butler G
PLoS Pathog; 2020 Jan; 16(1):e1008201. PubMed ID: 31945142
[TBL] [Abstract][Full Text] [Related]
3. Development of a CRISPR-Cas9 System for Efficient Genome Editing of
Norton EL; Sherwood RK; Bennett RJ
mSphere; 2017; 2(3):. PubMed ID: 28657072
[No Abstract] [Full Text] [Related]
4. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
5. Use of RNA-Protein Complexes for Genome Editing in Non-
Grahl N; Demers EG; Crocker AW; Hogan DA
mSphere; 2017; 2(3):. PubMed ID: 28657070
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
[No Abstract] [Full Text] [Related]
7. Candida albicans Gene Deletion with a Transient CRISPR-Cas9 System.
Min K; Ichikawa Y; Woolford CA; Mitchell AP
mSphere; 2016; 1(3):. PubMed ID: 27340698
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-Based CRISPR-Cas9 Editing in Multiple Candida Species.
Lombardi L; Butler G
Methods Mol Biol; 2022; 2542():13-40. PubMed ID: 36008654
[TBL] [Abstract][Full Text] [Related]
9. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
10. New insights of CRISPR technology in human pathogenic fungi.
Román E; Prieto D; Alonso-Monge R; Pla J
Future Microbiol; 2019 Sep; 14():1243-1255. PubMed ID: 31625446
[TBL] [Abstract][Full Text] [Related]
11. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple
Lombardi L; Oliveira-Pacheco J; Butler G
mSphere; 2019 Mar; 4(2):. PubMed ID: 30867327
[TBL] [Abstract][Full Text] [Related]
13. Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
Morio F; Lombardi L; Binder U; Loge C; Robert E; Graessle D; Bodin M; Lass-Flörl C; Butler G; Le Pape P
J Antimicrob Chemother; 2019 Aug; 74(8):2230-2238. PubMed ID: 31106355
[TBL] [Abstract][Full Text] [Related]
14. Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling.
Ravichandran M; Maddalo D
Front Genet; 2023; 14():1273994. PubMed ID: 37908590
[TBL] [Abstract][Full Text] [Related]
15. An Efficient, Rapid, and Recyclable System for CRISPR-Mediated Genome Editing in
Nguyen N; Quail MMF; Hernday AD
mSphere; 2017; 2(2):. PubMed ID: 28497115
[No Abstract] [Full Text] [Related]
16. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
Shen B; Brown KM; Lee TD; Sibley LD
mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
[TBL] [Abstract][Full Text] [Related]
17. Comparison of genome engineering using the CRISPR-Cas9 system in C. glabrata wild-type and lig4 strains.
Cen Y; Timmermans B; Souffriau B; Thevelein JM; Van Dijck P
Fungal Genet Biol; 2017 Oct; 107():44-50. PubMed ID: 28822858
[TBL] [Abstract][Full Text] [Related]
18. Progress and Challenges: Development and Implementation of CRISPR/Cas9 Technology in Filamentous Fungi.
Wang Q; Coleman JJ
Comput Struct Biotechnol J; 2019; 17():761-769. PubMed ID: 31312414
[TBL] [Abstract][Full Text] [Related]
19. Design, execution, and analysis of CRISPR-Cas9-based deletions and genetic interaction networks in the fungal pathogen Candida albicans.
Halder V; Porter CBM; Chavez A; Shapiro RS
Nat Protoc; 2019 Mar; 14(3):955-975. PubMed ID: 30737491
[TBL] [Abstract][Full Text] [Related]
20. Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape.
Ferreira R; David F; Nielsen J
J Ind Microbiol Biotechnol; 2018 Jul; 45(7):467-480. PubMed ID: 29362972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
